185 related articles for article (PubMed ID: 3157567)
1. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
Dixson S; Brumfitt W; Hamilton-Miller JM
Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of teicoplanin against gram-positive cocci.
Allouch P; Pina P; Chaplain C; Delarbre JM; Geffroy F; Grasmick CP; Marcolin M; Morel A; Pangon B; Rio Y; Sédaillan A
Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
[TBL] [Abstract][Full Text] [Related]
3. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
Kayaokay Y; Hasçelik G; Gür D; Akalin E
Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
5. Activity of rifampicin against staphylococci, with special reference to multiresistant strains.
Dixson S; Brumfitt W; Hamilton-Miller JM
J Antimicrob Chemother; 1984 Jun; 13 Suppl C():7-16. PubMed ID: 6236192
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
Kenny MT; Dulworth JK; Brackman MA
Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479
[TBL] [Abstract][Full Text] [Related]
7. Microbiological properties of teicoplanin.
Greenwood D
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Tuazon CU; Miller H
Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
[TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study: Staphylococcus and Enterococcus susceptibility to antibiotics.
Turano A; Ravizzola G; Peroni L; Ceruti T; Greco LM; Pitzus E; Santini G; Cresti S; Satta G
Eur J Epidemiol; 1994 Oct; 10(5):567-72. PubMed ID: 7859856
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
Bauernfeind A; Petermüller C
Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin.
Dixson S; Brumfitt W; Hamilton-Miller JM
Infection; 1985; 13(1):35-8. PubMed ID: 3845915
[TBL] [Abstract][Full Text] [Related]
16. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Carper HT; Sullivan GW; Mandell GL
J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
[TBL] [Abstract][Full Text] [Related]
19. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the new glycopeptide decaplanin.
Neu HC; Chin NX; Niu WW
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
